Metastatic neuroblastoma (NB) to the central nervous system (CNS): Improved outcome with combined modality including 131-I-8H9 or 131-I-3F8 radioimmunotherapy (RIT) delivered through the cerebrospinal fluid (CSF) Meeting Abstract

  

Authors:	Kramer, K.; Modak, S.; Kushner, B. H.; Souweidane, M.; Wolden, S.; Humm, J.; Zanzonico, P.; Smith-Jones, P.; Larson, S.; Cheung, N.
Abstract Title:	Metastatic neuroblastoma (NB) to the central nervous system (CNS): Improved outcome with combined modality including 131-I-8H9 or 131-I-3F8 radioimmunotherapy (RIT) delivered through the cerebrospinal fluid (CSF)
Meeting Title:	43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	25
Issue:	18 Suppl.
Meeting Dates:	2007 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2007-06-20
Start Page:	80s
Language:	English
ACCESSION:	WOS:000455043700331
PROVIDER:	wos
DOI:	10.1200/jco.2007.25.18_suppl.2022
Notes:	Meeting Abstract: 2022 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/141651